Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 271-240-3 | CAS number: 68526-92-1 A complex combination of hydrocarbons produced by the distillation of products from the hydrogenation of isotridecanal from the hydroformylation of dodecene. It consists predominantly of C10-12 olefins and paraffins and C13 alcohols and aldehydes and boils in the range of approximately 160°C to 253°C (320°F to 487°F).
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
A toxicokinetic assessment was performed based on the available data of the substance. Based on the physical/chemical properties of the substance, absorption factors for this substance are derived to be 50% (oral), 100% (inhalation) and 50% (dermal) for risk assessment purposes. The bioaccumulation potential is expected to be high.
Key value for chemical safety assessment
- Bioaccumulation potential:
- high bioaccumulation potential
- Absorption rate - oral (%):
- 50
- Absorption rate - dermal (%):
- 50
- Absorption rate - inhalation (%):
- 100
Additional information
A substance can enter the body via the lungs, the gastrointestinal tract, and the skin.
In general, a compound needs to be dissolved before it can be taken up from the gastro-intestinal tract after oral administration. Oxooil LS13 has a low water solubility (≤ 1.2mg/L), therefore it is not expected to dissolve into the gastrointestinal fluids, therefore uptake by passive diffusion is limited. Oxooil LS13 is a UVCB, the molecular weight of one of its main components (1-dodecene (and its isomers)) has an MW of 168.19. Based on the low molecular weight of its main component, Oxooil LS13 is favourable for absorption. Oxooil has a high log Pow (7.6-8.3), which makes the compound very hydrophobic. This characteristic will enable micellular solubilisation by bile salts in the gastro-intestinal tract which allows crossing of lipid biomembranes.
For risk assessment purposes oral absorption of Oxooil LS13 is set at 50%, based on its high log Pow, low water solubility and its low molecular weight. The results of the toxicity studies do not provide reasons to deviate from this proposed oral absorption factor.
Once absorbed, wide distribution of the test substance throughout the body is not expected based on its low water solubility. However, Oxooil LS13 has a low molecular weight which favours distribution. Overall, based on these data, distribution is expected to be limited.Excretion of Oxooil LS13 and its metabolites will occur via the bile (high molecular weight) or the urine (low molecular weight).Based on its high partition coefficient (7.6-8.3), it is likely that Oxooil LS13 will accumulate in adipose tissue.
The moderate vapour pressure (5 hPa at 20 °C) indicates that Oxooil LS13 can evaporate and reach the nasopharyncheal region or subsequently the tracheo/bronchial/pulmonary region via inhalation. If Oxooil LS13 reaches the tracheobronchial region, it is not likely to dissolve within the mucus lining the respiratory tract due to its low water solubility. However, if it dissolves into the mucus lining, based on its high log Pow, it is likely that micellular solubilisation will occur which will enable uptake of the substance by crossing of biomembranes.
Based on the above data, for risk assessment purposes the inhalation absorption of Oxooil LS13 is set at 100%.
When Oxooil LS13 comes in contact with the skin, the first layer of the skin, the stratum corneum, forms a barrier for hydrophilic compounds. Oxooil LS13 has a log Pow between 7.6-8.3, suggesting that the substance can be taken up in the stratum corneum. Since the substance is moderately volatile (5 hPa at 20 °C), penetration may be limited. Furthermore, due to its low water solubility (≤ 1.2mg/L), the transfer between the stratum corneum and the epidermis will be limited. According to the criteria given in the REACH Guidance, 10% dermal absorption will be considered in case MW >500 and log Pow <-1 or >4, otherwise 100% dermal absorption should be used. As the physical/chemical properties of Oxooil LS13 do not meet the criteria for limited dermal absorption (MW 168), for risk assessment purposes dermal absorption should be set at 100%. However, as it is generally accepted that dermal absorption does not exceed oral absorption, 50% dermal absorption of Oxooil LS13 is considered a realistic dermal absorption factor for risk assessment purposes.
Based on the high log Pow (7.6-8.3), the low water solubility (≤ 1.2mg/L) and the moderate vapour pressure (5 hPa at 20 °C), the dermal absorption for risk assessment purposes of Oxooil LS13 is set at 50%.The results of the toxicity studies do not provide reasons to deviate from this proposed dermal absorption factor.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.